Hyperneb 7% Respules (4ml Each)
By Hyperneb
Rx
7 Respules in a Boxes

Composition
Sodium Chloride(7% w/v)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
June, 2026

liver
Caution should be exercised when considering the use of Hyperneb 7% Respules (4ml Each) in relation to liver health. It is advised to be cautious and seek guidance from a healthcare professional, especially if you have any liver-related issues prior to using this medication. Monitoring liver function during the course of treatment is recommended. If unsure or if there is a history of liver problems, consulting with a doctor is crucial before starting to use Hyperneb 7% Respules (4ml Each).

kidney
No interaction or established safety advice related to kidney issues for Hyperneb 7% Respules (4ml Each). Consult with your doctor for proper guidance before using.

alcohol
Consult your doctor when consuming alcohol with Hyperneb 7% Respules (4ml Each).

driving
There are no known interactions with driving while using Hyperneb 7% Respules (4ml Each).

pregnancy
Hyperneb 7% Respules (4ml Each) may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will consider the risks and benefits before prescribing. Consult your doctor before use.

breastfeeding
It is better to consult your doctor before using Hyperneb 7% Respules (4ml Each).
Habit Forming | No |
Chemical Class | Alkali Metal Chlorides |
Therapeutic Class | - |
Action Class | Crystalloids |
₹211.75
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025